Michael J Wedemeyer1, Benjamin K Mueller2, Brian J Bender3, Jens Meiler4, Brian F Volkman5. 1. Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States. 2. Department of Chemistry, Vanderbilt University, Nashville, TN, United States; Center for Structural Biology, Vanderbilt University, Nashville, TN, United States. 3. Center for Structural Biology, Vanderbilt University, Nashville, TN, United States; Department of Pharmacology, Vanderbilt University, Nashville, TN, United States. 4. Department of Chemistry, Vanderbilt University, Nashville, TN, United States; Center for Structural Biology, Vanderbilt University, Nashville, TN, United States; Department of Pharmacology, Vanderbilt University, Nashville, TN, United States. 5. Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: bvolkman@gmail.com.
Abstract
Chemokines are soluble, secreted proteins that induce chemotaxis of leukocytes and other cells. Migratory cells can sense the chemokine concentration gradient following chemokine binding and activation of chemokine receptors, a subset of the G protein-coupled receptor (GPCR) superfamily. Chemokine receptor signaling plays a central role in cell migration during inflammatory responses as well as in cancer and other diseases. Given their important role in mediating essential pathologic and physiologic processes, chemokines and their receptors are attractive targets for therapeutic development. A better understanding of the molecular basis of chemokine-GPCR interactions will aid in the understanding of the mechanistic basis for chemokine function in disease-related processes, as well as aid in the design of new therapeutics. High resolution protein structures are critical for determining these mechanisms and investigating the interactions between approximately 50 chemokines and 20 chemokine receptors. Currently, three unique structures of chemokine-GPCR complexes have been determined and have greatly broadened our knowledge of this large protein-protein interaction. While these structures represent only a small fraction of clinically relevant chemokines and receptors, they can be exploited as scaffolds for homology modeling to understand the chemokine-GPCR interactions. This chapter presents a specialized methodology to construct and validate models of chemokine-GPCR complexes using the Rosetta software suite.
Chemokines are soluble, secreted proteins that induce chemotaxis of leukocytes and other cells. Migratory cells can sense the chemokine concentration gradient following chemokine binding and activation of chemokine receptors, a subset of the n class="Gene">G protein-coupled receptor (GPCR) superfamily. Chemokine receptor signaling plays a central role in cell migration during inflammatory responses as well as in cancer and other diseases. Given their important role in mediating essential pathologic and physiologic processes, chemokines and their receptors are attractive targets for therapeutic development. A better understanding of the molecular basis of chemokine-GPCR interactions will aid in the understanding of the mechanistic basis for chemokine function in disease-related processes, as well as aid in the design of new therapeutics. High resolution protein structures are critical for determining these mechanisms and investigating the interactions between approximately 50 chemokines and 20 chemokine receptors. Currently, three unique structures of chemokine-GPCR complexes have been determined and have greatly broadened our knowledge of this large protein-protein interaction. While these structures represent only a small fraction of clinically relevant chemokines and receptors, they can be exploited as scaffolds for homology modeling to understand the chemokine-GPCR interactions. This chapter presents a specialized methodology to construct and validate models of chemokine-GPCR complexes using the Rosetta software suite.
Authors: Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens Journal: Science Date: 2010-10-07 Impact factor: 47.728
Authors: Christine Oswald; Mathieu Rappas; James Kean; Andrew S Doré; James C Errey; Kirstie Bennett; Francesca Deflorian; John A Christopher; Ali Jazayeri; Jonathan S Mason; Miles Congreve; Robert M Cooke; Fiona H Marshall Journal: Nature Date: 2016-12-07 Impact factor: 49.962
Authors: Irina Kufareva; Martin Gustavsson; Yi Zheng; Bryan S Stephens; Tracy M Handel Journal: Annu Rev Biophys Date: 2017-05-22 Impact factor: 12.981
Authors: Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Norberto B De la Cruz; John C Haugner; Harihar Basnet; Thomas P Sakmar; Brian F Volkman Journal: Sci Signal Date: 2008-09-16 Impact factor: 8.192
Authors: Michael J Wedemeyer; Benjamin K Mueller; Brian J Bender; Jens Meiler; Brian F Volkman Journal: Biochem Biophys Res Commun Date: 2020-01-07 Impact factor: 3.575
Authors: Michael J Wedemeyer; Sarah A Mahn; Anthony E Getschman; Kyler S Crawford; Francis C Peterson; Adriano Marchese; John D McCorvy; Brian F Volkman Journal: J Biol Chem Date: 2020-08-11 Impact factor: 5.157